Responses of isolated Japanese monkey tracheal muscle to allergic mediators.
The responsiveness of isolated Japanese monkey (Macaca fuscata) tracheal muscle to antigen, carbachol, histamine, leukotriene C4 (LTC4), U-46619 and substance P (SP) was compared to that of isolated human trachea. Weak but persistent contraction was observed after the addition of antigen to isolated Japanese monkey tracheal muscle passively sensitized with monkey serum containing IgE antibody against Japanese cedar (Cryptomeria japonica) antigen. Unlike monkey tracheal muscle, a fair amount of contraction was caused by the antigen in human tracheal muscle passively sensitized with human atopic serum. When chopped, passively sensitized monkey or human lung tissue was challenged with antigen, a significant level of histamine was released from these tissues. In Japanese monkey tracheal muscle, histamine and SP produced no contraction of tracheal muscle, whereas carbachol, LTC4 and U-46619 caused contraction in a dose-dependent fashion. Contrary to the Japanese monkey, histamine and carbachol caused distinct contraction in tracheal muscle obtained from the cotton-headed tamarin (Saguinus oedipus). In human tracheal muscle, all test substances (carbachol, histamine, LTC4, U-46619 and SP) induced clear contraction. In lung parenchyma obtained from Japanese monkey, histamine induced a weak contraction, and this histamine-induced contraction was also inhibited by pyrilamine (H1 receptor antagonist). These results indicate that antigen-induced contraction of isolated Japanese monkey tracheal muscle, passively sensitized with monkey atopic serum, is not a useful model for human allergic bronchoconstriction in vitro because of the unresponsiveness of tracheal muscle to histamine and SP.
Nagai
H
H
Department of Pharmacology, Gifu Pharmaceutical University, Japan.
Kondo
M
M
Koda
A
A
Nakamura
S
S
Hashimoto
M
M
Yanagihara
Y
Y
Daikoku
M
M
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000485:Allergens / Q000276:immunology*; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D006636:Histamine Release; D006801:Humans; D007116:Immunization, Passive; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects / Q000502:physiology; D008251:Macaca / Q000276:immunology*; D008925:Mites / Q000276:immunology; D009119:Muscle Contraction / Q000187:drug effects; D011058:Pollen / Q000276:immunology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D013189:SRS-A / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D014132:Trachea / Q000033:anatomy & histology / Q000276:immunology*
D000485:Allergens; D011450:Prostaglandin Endoperoxides, Synthetic; D013189:SRS-A; D013373:Substance P; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D002217:Carbachol